Midazolam Hydrochloride

盐酸咪达唑仑

Report date: 2022/09/05 11:23:26
NME

Base Information

Drug NameMidazolam Hydrochloride
Drug Alias Name咪哒唑仑Midazolamum速眠安咪唑安定盐酸咪唑二氮卓 +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSedationAnxietyDrug-Related Side Effects and Adverse Reactions +[8] 
Global Approved IndicationsSedationEpilepsy
Approved Indications in ChinaSedation
Original Approved Country/TerritoryUnited States
Original Approved Date1985/12/20
Country/TerritoryCanadaUnited StatesEU +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeuraxpharmWashington State University
Inactive CompaniesShireF. Hoffmann-La Roche AgUniversity Of Pennsylvania +[4] 
Active IndicationsSedationDrug-Related Side Effects and Adverse ReactionsDiabetes Mellitus, Type 2 +[4] 
Inactive IndicationsAnxietyPeripheral Nervous System DiseasesStatus Epilepticus +[4] 

Other Information

ATC CodeN05CD08
Related LinksWikipediaDrugBankKEGG